Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01919086
What this trial is testing

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
Memorial Sloan Kettering Cancer Center 30
Not applicableLooking for participantsNCT07564219
What this trial is testing

BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)CAR T CellsBispecific Antibodies
Universitätsklinikum Hamburg-Eppendorf 45
Not applicableStudy completedNCT03433365
What this trial is testing

Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD)

Who this might be right for
Multiple Myeloma
Fondazione EMN Italy Onlus 70
Early research (Phase 1)Study completedNCT00861510
What this trial is testing

A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid Malignancies

Who this might be right for
Lymphoma, Mantle-cellLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Hairy Cell+2 more
National Heart, Lung, and Blood Institute (NHLBI) 16
Not applicableNot Yet RecruitingNCT07684274
What this trial is testing

Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics

Who this might be right for
Multiple Myeloma (MM)Smoldering Multiple Myeloma (SMM)MGUS
The First Affiliated Hospital with Nanjing Medical University 290
Testing effectiveness (Phase 2)UnknownNCT03795597
What this trial is testing

Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Loyola University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029776
What this trial is testing

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)
University of Arkansas 50
Not applicableUnknownNCT06154317
What this trial is testing

Study for Validation of Target Therapy in Multiple Myeloma Cells From Patients With miRNAs Released From B Cells, and Study of the Bone Marrow Tumor Microenvironment (Microenvironment of MM)

Who this might be right for
Multiple Myeloma
Centro di Riferimento Oncologico - Aviano 30
Early research (Phase 1)Ended earlyNCT02663518
What this trial is testing

A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors

Who this might be right for
Hematologic MalignanciesSolid Tumor
Pfizer 249
Testing effectiveness (Phase 2)Active Not RecruitingNCT04176718
What this trial is testing

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Who this might be right for
Multiple MyelomaRefractory Multiple MyelomaMultiple Myeloma in Relapse+1 more
Andrew Yee, MD 44
Not applicableUnknownNCT03122327
What this trial is testing

CGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.

Who this might be right for
Multiple MyelomaComprehensive Geriatric Assessment
Peking Union Medical College Hospital 200
Post-approval studies (Phase 4)Ended earlyNCT02773550
What this trial is testing

Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Basque Health Service 24
Early research (Phase 1)Study completedNCT02513186
What this trial is testing

Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation

Who this might be right for
Plasma Cell Myeloma
Sanofi 90
Testing effectiveness (Phase 2)Study completedNCT02204241
What this trial is testing

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 36
Not applicableLooking for participantsNCT06697483
What this trial is testing

Risk Stratification and MRD-driven Maintenance for MM After ASCT

Who this might be right for
Multiple Myeloma
Peking University People's Hospital 100
Early research (Phase 1)Ended earlyNCT04178902
What this trial is testing

The Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Cancer
AbbVie 8
Early research (Phase 1)Active Not RecruitingNCT02886065
What this trial is testing

PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM

Who this might be right for
Smoldering Multiple Myeloma
Massachusetts General Hospital 19
Testing effectiveness (Phase 2)UnknownNCT03018405
What this trial is testing

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

Who this might be right for
Acute Myeloid Leukemia/Myelodysplastic SyndromeMultiple Myeloma (MM)
Celyad Oncology SA 146
Testing effectiveness (Phase 2)UnknownNCT03605056
What this trial is testing

Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

Who this might be right for
Multiple Myeloma
Peng Liu 25
Testing effectiveness (Phase 2)Study completedNCT02206425
What this trial is testing

Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Oncotherapeutics 45
Next Page